NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.06
-0.48 (-7.27%)
Jul 29, 2026, 11:13 AM EDT - Market open
NeurAxis Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | - | - | 0.08 | 0.25 | 0.32 |
Cash & Short-Term Investments | - | - | - | 0.08 | 0.25 | 0.32 |
Cash Growth | - | - | - | -69.03% | -20.93% | -83.07% |
Accounts Receivable | - | - | - | 0.07 | 0.17 | 0.12 |
Inventory | - | - | - | 0.02 | 0.05 | 0.04 |
Other Current Assets | - | - | - | 0.07 | 0 | 0.02 |
Total Current Assets | - | - | - | 0.24 | 0.48 | 0.49 |
Net Property, Plant & Equipment | 0.31 | 0.34 | 0.37 | 0.16 | 0.19 | 0.25 |
Other Intangible Assets | - | - | - | 0.11 | 0.08 | 0.02 |
Other Long-Term Assets | 0.02 | 0.06 | 0.02 | - | 0.74 | - |
Total Assets | 8.75 | 6.4 | 4.76 | 0.51 | 1.48 | 0.76 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.31 | 0.14 | 0.6 | 1.2 | 1.59 | 0.48 |
Accrued Expenses | - | - | - | 0.4 | 0.83 | 0.56 |
Short-Term Debt | 0.1 | 0.15 | 0.15 | 0.15 | 0.49 | 0.06 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.19 |
Current Portion of Leases | - | - | - | 0.05 | 0.03 | 0.03 |
Unearned Revenue | - | - | - | 0.07 | 0.06 | 0.07 |
Other Current Liabilities | - | - | - | 0.01 | 3.97 | 0.03 |
Total Current Liabilities | 0.41 | 0.29 | 0.75 | 1.89 | 6.98 | 1.42 |
Long-Term Debt | - | - | - | - | - | 0.05 |
Long-Term Leases | - | - | - | 0.03 | 0.08 | 0.11 |
Other Long-Term Liabilities | - | 0.01 | - | - | - | - |
Total Long-Term Liabilities | - | 0.01 | - | 0.03 | 0.08 | 0.16 |
Total Liabilities | 3 | 3 | 2.69 | 1.91 | 7.05 | 1.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Preferred Stock | 0 | 0 | 0 | - | 0 | 0 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Additional Paid-in Capital | - | - | - | 47.15 | 28.36 | 28.32 |
Retained Earnings | - | - | - | -48.56 | -33.93 | -29.15 |
Shareholders' Equity | 0.02 | 0.01 | 0.01 | -1.4 | -5.57 | -0.83 |
Total Liabilities & Equity | 8.75 | 6.4 | 4.76 | 0.51 | 1.48 | 0.76 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.1 | 0.15 | 0.15 | 0.22 | 0.6 | 0.44 |
Net Cash (Debt) | -0.1 | -0.15 | -0.15 | -0.15 | -0.35 | -0.12 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.01 | -0.02 | -0.02 | -0.04 | -0.17 | -0.06 |
Book Value | 0.02 | 0.01 | 0.01 | -1.4 | -5.57 | -0.83 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | -0.43 | -2.78 | -0.42 |
Tangible Book Value | 0.02 | 0.01 | 0.01 | -1.51 | -5.65 | -0.85 |
Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | -0.46 | -2.82 | -0.43 |